Accelerate Diagnostics Stock Shares Owned By Institutions

AXDX Stock  USD 1.70  0.13  8.28%   
Accelerate Diagnostics fundamentals help investors to digest information that contributes to Accelerate Diagnostics' financial success or failures. It also enables traders to predict the movement of Accelerate Stock. The fundamental analysis module provides a way to measure Accelerate Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Accelerate Diagnostics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Accelerate Diagnostics Company Shares Owned By Institutions Analysis

Accelerate Diagnostics' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

More About Shares Owned By Institutions | All Equity Analysis

Current Accelerate Diagnostics Shares Owned By Institutions

    
  17.45 %  
Most of Accelerate Diagnostics' fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Accelerate Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Accelerate Shares Owned By Institutions Driver Correlations

Understanding the fundamental principles of building solid financial models for Accelerate Diagnostics is extremely important. It helps to project a fair market value of Accelerate Stock properly, considering its historical fundamentals such as Shares Owned By Institutions. Since Accelerate Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Accelerate Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Accelerate Diagnostics' interrelated accounts and indicators.
0.430.08-0.210.140.250.511.0-0.57-0.1-0.320.5-0.47-0.54-0.060.40.510.810.350.66-0.050.420.370.17
0.43-0.820.55-0.18-0.51-0.550.47-0.12-0.250.66-0.27-0.09-0.13-0.251.0-0.520.4-0.39-0.05-0.220.550.56-0.01
0.08-0.82-0.660.140.690.840.03-0.140.23-0.830.5-0.11-0.090.19-0.830.820.20.560.40.16-0.27-0.30.1
-0.210.55-0.66-0.8-0.86-0.66-0.160.52-0.690.9-0.930.440.47-0.390.58-0.59-0.07-0.98-0.74-0.350.720.740.11
0.14-0.180.14-0.80.650.210.11-0.550.75-0.560.81-0.45-0.470.45-0.210.12-0.130.830.570.42-0.76-0.79-0.25
0.25-0.510.69-0.860.650.660.21-0.310.66-0.850.82-0.29-0.330.29-0.530.620.190.840.620.26-0.5-0.53-0.11
0.51-0.550.84-0.660.210.660.47-0.380.05-0.890.65-0.32-0.340.2-0.570.950.380.620.620.18-0.07-0.140.25
1.00.470.03-0.160.110.210.47-0.56-0.12-0.280.46-0.47-0.52-0.080.450.470.820.310.63-0.070.450.40.16
-0.57-0.12-0.140.52-0.55-0.31-0.38-0.56-0.30.42-0.680.640.46-0.14-0.1-0.34-0.39-0.62-0.64-0.130.210.230.02
-0.1-0.250.23-0.690.750.660.05-0.12-0.3-0.410.61-0.3-0.170.09-0.270.08-0.090.710.430.06-0.76-0.67-0.57
-0.320.66-0.830.9-0.56-0.85-0.89-0.280.42-0.41-0.840.360.38-0.340.68-0.83-0.18-0.85-0.66-0.310.440.49-0.03
0.5-0.270.5-0.930.810.820.650.46-0.680.61-0.84-0.56-0.580.27-0.310.610.280.980.860.25-0.53-0.54-0.15
-0.47-0.09-0.110.44-0.45-0.29-0.32-0.470.64-0.30.36-0.560.56-0.12-0.05-0.29-0.31-0.52-0.53-0.110.180.20.02
-0.54-0.13-0.090.47-0.47-0.33-0.34-0.520.46-0.170.38-0.580.56-0.13-0.07-0.3-0.33-0.54-0.56-0.110.190.20.02
-0.06-0.250.19-0.390.450.290.2-0.08-0.140.09-0.340.27-0.12-0.13-0.26-0.09-0.140.320.161.0-0.35-0.60.62
0.41.0-0.830.58-0.21-0.53-0.570.45-0.1-0.270.68-0.31-0.05-0.07-0.26-0.540.38-0.42-0.08-0.230.570.58-0.01
0.51-0.520.82-0.590.120.620.950.47-0.340.08-0.830.61-0.29-0.3-0.09-0.540.40.570.58-0.11-0.02-0.010.02
0.810.40.2-0.07-0.130.190.380.82-0.39-0.09-0.180.28-0.31-0.33-0.140.380.40.190.51-0.130.540.50.14
0.35-0.390.56-0.980.830.840.620.31-0.620.71-0.850.98-0.52-0.540.32-0.420.570.190.820.29-0.66-0.67-0.16
0.66-0.050.4-0.740.570.620.620.63-0.640.43-0.660.86-0.53-0.560.16-0.080.580.510.820.14-0.29-0.3-0.05
-0.05-0.220.16-0.350.420.260.18-0.07-0.130.06-0.310.25-0.11-0.111.0-0.23-0.11-0.130.290.14-0.31-0.570.64
0.420.55-0.270.72-0.76-0.5-0.070.450.21-0.760.44-0.530.180.19-0.350.57-0.020.54-0.66-0.29-0.310.960.31
0.370.56-0.30.74-0.79-0.53-0.140.40.23-0.670.49-0.540.20.2-0.60.58-0.010.5-0.67-0.3-0.570.960.08
0.17-0.010.10.11-0.25-0.110.250.160.02-0.57-0.03-0.150.020.020.62-0.010.020.14-0.16-0.050.640.310.08
Click cells to compare fundamentals
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition

Based on the latest financial disclosure, 17.45% of Accelerate Diagnostics are shares owned by institutions. This is 60.91% lower than that of the Life Sciences Tools & Services sector and 68.5% lower than that of the Health Care industry. The shares owned by institutions for all United States stocks is 55.5% higher than that of the company.

Accelerate Shares Owned By Institutions Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Accelerate Diagnostics' direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Accelerate Diagnostics could also be used in its relative valuation, which is a method of valuing Accelerate Diagnostics by comparing valuation metrics of similar companies.
Accelerate Diagnostics is currently under evaluation in shares owned by institutions category among its peers.

Accelerate Fundamentals

About Accelerate Diagnostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Accelerate Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accelerate Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accelerate Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Accelerate Stock Analysis

When running Accelerate Diagnostics' price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.